Transcriptomics Market Size, Share, and Outlook, H2-2025 Report- By Technology (Microarray, Real-time Quantitative Polymerase Chain Reaction (Q-PCR), Sequencing Technologies), By Product (Consumables, Instruments, Others), By Application (Diagnostics and
Description
Transcriptomics Market Outlook
The global Transcriptomics Market Size is valued at $7.9 Billion in 2025 and is forecast to reach $11.3 Billion in 2032 at a CAGR of 5.2%.
The Transcriptomics Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on Transcriptomics Market segments across 22 countries from 2021 to 2032. Key segments covered include By Technology (Microarray, Real-time Quantitative Polymerase Chain Reaction (Q-PCR), Sequencing Technologies), By Product (Consumables, Instruments, Others), By Application (Diagnostics and Disease Profiling, Drug Discovery, Others), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
Transcriptomics Market Insights, 2025
The transcriptomics market in 2025 is driven by breakthroughs in single-cell RNA sequencing, spatial transcriptomics, and long-read sequencing technologies, enabling unprecedented resolution in gene expression profiling across diverse biological systems. Advances in microfluidics and barcoding techniques allow high-throughput, cost-effective analysis of thousands of cells, accelerating biomarker discovery, drug development, and precision medicine applications. Integration with multi-omics data and AI-powered bioinformatics tools enhances data interpretation and biological insights. Clinical translation includes diagnostics for cancer subtyping, autoimmune disorders, and infectious diseases, with emerging use in monitoring treatment response. The market is supported by expanding public and private investments in large-scale transcriptomic databases and consortia. Ethical and data privacy considerations are increasingly addressed through standardized frameworks. Collaborative platforms promote data sharing and reproducibility. Automation and cloud computing solutions improve scalability and accessibility for research and clinical laboratories.
Five Trends Shaping the Global Transcriptomics Market in 2025 and Beyond
The global Transcriptomics Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the Transcriptomics Industry?
The Transcriptomics Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, Transcriptomics Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
Transcriptomics Market Segment Insights
The Transcriptomics Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Technology (Microarray, Real-time Quantitative Polymerase Chain Reaction (Q-PCR), Sequencing Technologies), By Product (Consumables, Instruments, Others), By Application (Diagnostics and Disease Profiling, Drug Discovery, Others). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
Transcriptomics Industry Value Chain
The chapter identifies potential companies and their operations across the global Transcriptomics Industry ecosystem. It assists decision-makers in evaluating global Transcriptomics Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the Transcriptomics Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific Transcriptomics Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for Transcriptomics Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States Transcriptomics Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Transcriptomics Market.
Europe Transcriptomics Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for Transcriptomics Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for Transcriptomics Industry competitiveness. The report analyses the key Transcriptomics Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American Transcriptomics Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international Transcriptomics Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa Transcriptomics Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for Transcriptomics Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How Transcriptomics Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the Transcriptomics Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes 10x Genomics, Agilent Technologies Inc, BGI Genomics, Bio-Rad Laboratories Inc, Dovetail Genomics, F. Hoffmann-La Roche AG, Fluidigm Corp, GE Healthcare, Illumina Inc, Merck KGaA, Natera Inc, PerkinElmer Inc, Promega Corp, Qiagen NV, Thermo Fisher Scientific. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
Transcriptomics Market Scope
Leading Segments
By Technology
Microarray
Real-time Quantitative Polymerase Chain Reaction (Q-PCR)
Sequencing Technologies
By Product
Consumables
Instruments
Others
By Application
Diagnostics and Disease Profiling
Drug Discovery
Others
Leading Companies
10x Genomics
Agilent Technologies Inc
BGI Genomics
Bio-Rad Laboratories Inc
Dovetail Genomics
F. Hoffmann-La Roche AG
Fluidigm Corp
GE Healthcare
Illumina Inc
Merck KGaA
Natera Inc
PerkinElmer Inc
Promega Corp
Qiagen NV
Thermo Fisher Scientific
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report Make informed decisions with 12-year forecasts across 22 countries and multiple market segments. Evaluate regulatory impacts, sustainability trends, and disruptive technologies shaping the chemicals industry. Gain insights into the competitive landscape, including company profiles, financials, and strategic moves. Build an integrated understanding of the chemicals ecosystem across upstream, midstream, and downstream operations. Leverage insights on circular economy initiatives, digitalization, and carbon-neutral strategies driving the next decade. Assess risks and opportunities with scenario-based forecasts tailored to different growth conditions. Access the report in multiple formats (PDF, Excel, PPT) for easier integration into strategic planning.
The global Transcriptomics Market Size is valued at $7.9 Billion in 2025 and is forecast to reach $11.3 Billion in 2032 at a CAGR of 5.2%.
The Transcriptomics Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on Transcriptomics Market segments across 22 countries from 2021 to 2032. Key segments covered include By Technology (Microarray, Real-time Quantitative Polymerase Chain Reaction (Q-PCR), Sequencing Technologies), By Product (Consumables, Instruments, Others), By Application (Diagnostics and Disease Profiling, Drug Discovery, Others), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
Transcriptomics Market Insights, 2025
The transcriptomics market in 2025 is driven by breakthroughs in single-cell RNA sequencing, spatial transcriptomics, and long-read sequencing technologies, enabling unprecedented resolution in gene expression profiling across diverse biological systems. Advances in microfluidics and barcoding techniques allow high-throughput, cost-effective analysis of thousands of cells, accelerating biomarker discovery, drug development, and precision medicine applications. Integration with multi-omics data and AI-powered bioinformatics tools enhances data interpretation and biological insights. Clinical translation includes diagnostics for cancer subtyping, autoimmune disorders, and infectious diseases, with emerging use in monitoring treatment response. The market is supported by expanding public and private investments in large-scale transcriptomic databases and consortia. Ethical and data privacy considerations are increasingly addressed through standardized frameworks. Collaborative platforms promote data sharing and reproducibility. Automation and cloud computing solutions improve scalability and accessibility for research and clinical laboratories.
Five Trends Shaping the Global Transcriptomics Market in 2025 and Beyond
The global Transcriptomics Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the Transcriptomics Industry?
The Transcriptomics Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, Transcriptomics Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
Transcriptomics Market Segment Insights
The Transcriptomics Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Technology (Microarray, Real-time Quantitative Polymerase Chain Reaction (Q-PCR), Sequencing Technologies), By Product (Consumables, Instruments, Others), By Application (Diagnostics and Disease Profiling, Drug Discovery, Others). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
Transcriptomics Industry Value Chain
The chapter identifies potential companies and their operations across the global Transcriptomics Industry ecosystem. It assists decision-makers in evaluating global Transcriptomics Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the Transcriptomics Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific Transcriptomics Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for Transcriptomics Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States Transcriptomics Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Transcriptomics Market.
Europe Transcriptomics Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for Transcriptomics Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for Transcriptomics Industry competitiveness. The report analyses the key Transcriptomics Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American Transcriptomics Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international Transcriptomics Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa Transcriptomics Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for Transcriptomics Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How Transcriptomics Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the Transcriptomics Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes 10x Genomics, Agilent Technologies Inc, BGI Genomics, Bio-Rad Laboratories Inc, Dovetail Genomics, F. Hoffmann-La Roche AG, Fluidigm Corp, GE Healthcare, Illumina Inc, Merck KGaA, Natera Inc, PerkinElmer Inc, Promega Corp, Qiagen NV, Thermo Fisher Scientific. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
Transcriptomics Market Scope
Leading Segments
By Technology
Microarray
Real-time Quantitative Polymerase Chain Reaction (Q-PCR)
Sequencing Technologies
By Product
Consumables
Instruments
Others
By Application
Diagnostics and Disease Profiling
Drug Discovery
Others
Leading Companies
10x Genomics
Agilent Technologies Inc
BGI Genomics
Bio-Rad Laboratories Inc
Dovetail Genomics
F. Hoffmann-La Roche AG
Fluidigm Corp
GE Healthcare
Illumina Inc
Merck KGaA
Natera Inc
PerkinElmer Inc
Promega Corp
Qiagen NV
Thermo Fisher Scientific
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report
Table of Contents
200 Pages
- 1. Table of Contents
- List of Figures and Tables
- 2. Executive Summary
- 2.1 Key Highlights
- 2.1.1 Transcriptomics Market Size Outlook, 2018-2024 and 2025-2032
- 2.1.2 Largest Transcriptomics Market Types and Applications
- 2.1.3 Fastest Growing Segments
- 2.1.4 Potential Markets
- 2.1.5 Market Concentration
- 2.2 Market Scope and Segmentation
- 2.2.1 Market Scope- Segments
- 2.2.2 Market Scope- Countries
- 2.2.3 Macroeconomic and Demographic Outlook
- 2.2.4 Abbreviations
- 2.2.5 Units and Currency Conversions
- 3. Research Methodology
- 3.1 Primary Research Surveys
- 3.2 Secondary Data Sources
- 3.3 Data Triangulation
- 3.4 Forecast Methodology
- 3.5 Assumptions and Limitations
- 4. Introduction to Global Transcriptomics Market in 2025
- 4.1 Industry Panorama
- 4.2 Leading Companies Profiled in the Study
- 4.3 Asia Pacific Markets offer Robust Market Prospects for New Entrants
- 4.4 Market Dynamics
- 4.4.1 Market Dynamics- Trends and Drivers
- 4.4.2 Market Dynamics- Opportunities and Challenges
- 4.5 Regional Analysis
- 4.6 Porter’s Five Force Analysis
- 4.6.1 Intensity of Competitive Rivalry
- 4.6.2 Threat of New Entrants
- 4.6.3 Threat of Substitutes
- 4.6.4 Bargaining Power of Buyers
- 4.6.5 Bargaining Power of Suppliers
- 4.7 Transcriptomics Market Industry Value Chain Analysis
- 4.7.1 Stage of Value Chain
- 4.7.2 Key Activities of Companies
- 4.7.3 Companies Included in Each Stage
- 4.7.4 Key Insights
- 5. Transcriptomics Market Outlook to 2032
- 5.1 Market Size Forecast by Type, 2021-2024 and 2025-2032
- 5.2 Market Size Forecast by Application, 2021-2024 and 2024-2032
- 5.3 Market Size Forecast by Geography, 2021-2024 and 2024-2032
- By Technology
- Microarray
- Real-time Quantitative Polymerase Chain Reaction (Q-PCR)
- Sequencing Technologies
- By Product
- Consumables
- Instruments
- Others
- By Application
- Diagnostics and Disease Profiling
- Drug Discovery
- Others
- 6. Global Transcriptomics Market Outlook across Growth Scenarios
- 6.1 Low Growth Scenario
- 6.2 Base/Reference Case
- 6.3 High Growth Scenario
- 6. North America Transcriptomics Market Size Outlook
- 6.1 Key Market Statistics, 2024
- 6.2 North America Transcriptomics Market Trends and Growth Opportunities
- 6.2.1 North America Transcriptomics Market Outlook by Type
- 6.2.2 North America Transcriptomics Market Outlook by Application
- 6.3 North America Transcriptomics Market Outlook by Country
- 6.3.1 The US Transcriptomics Market Outlook, 2021- 2032
- 6.3.2 Canada Transcriptomics Market Outlook, 2021- 2032
- 6.3.3 Mexico Transcriptomics Market Outlook, 2021- 2032
- 7. Europe Transcriptomics Market Size Outlook
- 7.1 Key Market Statistics, 2024
- 7.2 Europe Transcriptomics Market Trends and Growth Opportunities
- 7.2.1 Europe Transcriptomics Market Outlook by Type
- 7.2.2 Europe Transcriptomics Market Outlook by Application
- 7.3 Europe Transcriptomics Market Outlook by Country
- 7.3.2 Germany Transcriptomics Market Outlook, 2021- 2032
- 7.3.3 France Transcriptomics Market Outlook, 2021- 2032
- 7.3.4 The UK Transcriptomics Market Outlook, 2021- 2032
- 7.3.5 Spain Transcriptomics Market Outlook, 2021- 2032
- 7.3.6 Italy Transcriptomics Market Outlook, 2021- 2032
- 7.3.7 Russia Transcriptomics Market Outlook, 2021- 2032
- 7.3.8 Rest of Europe Transcriptomics Market Outlook, 2021- 2032
- 8. Asia Pacific Transcriptomics Market Size Outlook
- 8.1 Key Market Statistics, 2024
- 8.2 Asia Pacific Transcriptomics Market Trends and Growth Opportunities
- 8.2.1 Asia Pacific Transcriptomics Market Outlook by Type
- 8.2.2 Asia Pacific Transcriptomics Market Outlook by Application
- 8.3 Asia Pacific Transcriptomics Market Outlook by Country
- 8.3.1 China Transcriptomics Market Outlook, 2021- 2032
- 8.3.2 India Transcriptomics Market Outlook, 2021- 2032
- 8.3.3 Japan Transcriptomics Market Outlook, 2021- 2032
- 8.3.4 South Korea Transcriptomics Market Outlook, 2021- 2032
- 8.3.5 Australia Transcriptomics Market Outlook, 2021- 2032
- 8.3.6 South East Asia Transcriptomics Market Outlook, 2021- 2032
- 8.3.7 Rest of Asia Pacific Transcriptomics Market Outlook, 2021- 2032
- 9. South America Transcriptomics Market Size Outlook
- 9.1 Key Market Statistics, 2024
- 9.2 South America Transcriptomics Market Trends and Growth Opportunities
- 9.2.1 South America Transcriptomics Market Outlook by Type
- 9.2.2 South America Transcriptomics Market Outlook by Application
- 9.3 South America Transcriptomics Market Outlook by Country
- 9.3.1 Brazil Transcriptomics Market Outlook, 2021- 2032
- 9.3.2 Argentina Transcriptomics Market Outlook, 2021- 2032
- 9.3.3 Rest of South and Central America Transcriptomics Market Outlook, 2021- 2032
- 10. Middle East and Africa Transcriptomics Market Size Outlook
- 10.1 Key Market Statistics, 2024
- 10.2 Middle East and Africa Transcriptomics Market Trends and Growth Opportunities
- 10.2.1 Middle East and Africa Transcriptomics Market Outlook by Type
- 10.2.2 Middle East and Africa Transcriptomics Market Outlook by Application
- 10.3 Middle East and Africa Transcriptomics Market Outlook by Country
- 10.3.1 Saudi Arabia Transcriptomics Market Outlook, 2021- 2032
- 10.3.2 The UAE Transcriptomics Market Outlook, 2021- 2032
- 10.3.3 Rest of Middle East Transcriptomics Market Outlook, 2021- 2032
- 10.3.4 South Africa Transcriptomics Market Outlook, 2021- 2032
- 10.3.5 Egypt Transcriptomics Market Outlook, 2021- 2032
- 10.3.6 Rest of Africa Transcriptomics Market Outlook, 2021- 2032
- 11. Company Profiles
- 11.1 Leading 10 Companies
- 10x Genomics
- Agilent Technologies Inc
- BGI Genomics
- Bio-Rad Laboratories Inc
- Dovetail Genomics
- F. Hoffmann-La Roche AG
- Fluidigm Corp
- GE Healthcare
- Illumina Inc
- Merck KGaA
- Natera Inc
- PerkinElmer Inc
- Promega Corp
- Qiagen NV
- Thermo Fisher Scientific
- 11.2 Overview
- 11.3 Products and Services
- 11.4 SWOT Profile
- 12. Appendix
- 12.1 Subscription Options
- 12.2 Customization Options
- 12.3 Publisher Details
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
